Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
Introduction It has been observed that intravenous iron administration may suppress endogenous production of erythropoietin (EPO). We postulate that this effect may be mediated by increased FGF-23 secretion.Aim of the study To evaluate the short-term effect of intravenous iron sucrose administration...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2022.2164305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|